Genitourinary Cancers Special Issue
Within the genitourinary cancer space, there have been many treatment advances over the past year.
As part of the “Speaking Out” series, a radiation oncologist discusses the benefits of MRI-guided stereotactic body radiation therapy.
Antibody-drug conjugates represent a paradigm shift for patients with cancer and providers.
Advertisement
Advertisement
Trending on CURE
1
Tukysa Makes Waves as Firstline Maintenance in HER2+ Breast Cancer
2
Just Diagnosed with Cancer? Read This Before You Google Anything
3
Tukysa May Be ‘Patient Friendly’ Frontline Maintenance Option in HER2+ Breast Cancer
4
The Current Treatment Landscape in Multiple Myeloma
5